Calamos Advisors LLC Sells 3,252 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Calamos Advisors LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 112,220 shares of the medical equipment provider’s stock after selling 3,252 shares during the period. Calamos Advisors LLC’s holdings in Intuitive Surgical were worth $58,574,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 28,843 shares of company stock worth $15,357,560. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $578.55 on Tuesday. The company has a market cap of $206.07 billion, a P/E ratio of 90.26, a P/E/G ratio of 5.51 and a beta of 1.39. The stock’s 50-day moving average is $550.40 and its 200-day moving average is $510.02. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Ratings Changes

ISRG has been the topic of several recent research reports. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.